Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.

× No keyword cloud information.

85 in total

1. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.

Authors: B J Riis; P Rødbro; C Christiansen
Journal: Calcif Tissue Int Date: 1986-06 Impact factor: 4.333

2. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens.

Authors: M L Padwick; J Pryse-Davies; M I Whitehead
Journal: N Engl J Med Date: 1986-10-09 Impact factor: 91.245

3. [Consensus conference on osteoporosis].

Authors: O L Bijvoet
Journal: Ned Tijdschr Geneeskd Date: 1986-03-29

4. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.

Authors: J Jensen; L Nilas; C Christiansen
Journal: Br J Obstet Gynaecol Date: 1986-06

5. Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women.

Authors: J Jensen; B J Riis; V Strøm; L Nilas; C Christiansen
Journal: Am J Obstet Gynecol Date: 1987-01 Impact factor: 8.661

6. Prediction of rapid bone loss in postmenopausal women.

Authors: C Christiansen; B J Riis; P Rødbro
Journal: Lancet Date: 1987-05-16 Impact factor: 79.321

7. Prediction of postmenopausal fracture risk with use of bone mineral measurements.

Authors: R D Wasnich; P D Ross; L K Heilbrun; J M Vogel
Journal: Am J Obstet Gynecol Date: 1985-12-01 Impact factor: 8.661

8. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy.

Authors: P A Wingo; P M Layde; N C Lee; G Rubin; H W Ory
Journal: JAMA Date: 1987-01-09 Impact factor: 56.272

9. Long-term hormone implant therapy--hormonal and clinical effects.

Authors: D H Barlow; H I Abdalla; A D Roberts; F Al Azzawi; I Leggate; D M Hart
Journal: Obstet Gynecol Date: 1986-03 Impact factor: 7.661

10. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors: T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal: Circulation Date: 1987-06 Impact factor: 29.690

1 in total

1. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.

Authors: B Stein; M X Yang
Journal: Mol Cell Biol Date: 1995-09 Impact factor: 4.272

1 in total